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Increase Postpartum Gestational Diabetes Screening
Providence Women’s Clinics
MethodIntroduction Conclusions
Smart nurses are using 
checklists, nurse order 
sets, love and grit to get to 
Diabetic women did not 
get follow up screening 
after delivery.
Nurses are finding a way 
to screen more women
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Results
We’re on our way up!
Increase GDM Postpartum Screening
AIM STATEMENT PRIMARY DRIVERS SECONDARY DRIVERS PDSA CYCLES
Increase 
postpartum 
screening rates 
to 40% for 
patient 
identified with 
diabetes in 
pregnancy by 
December 
2018
Reach the 10% of our 
patients GDM affects with 
calls and letters
Create diabetic patient list 
in Epic
Identify targets
25% of patients will 
become diabetic after 
pregnancy
RN order sets
Remove barriers to
testing and provide 
searchable field
Postpartum screening is
critical to a lifetime of 
care
Update RN GDM Dx 
checklist in Epic 
Improve communication
with PCPs  for at risk 
patients
Enhanced understanding 
of importance of 
postpartum screening
Reach the 10% of our 
patients GDM affects with 
calls and letters
Increase awareness of
providers and patients re:
importance of screening
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